SF3B3
Splicing factor 3B subunit 3
Also known as: KIAA0017, RSE1, SAP130, SF3b130, SF3B3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15393
- Gene
- SF3B3
- Ensembl
- ENSG00000189091
- Chromosome
- 16
- Canonical length
- 1217 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Nucleoli rim
OverviewNCBI Gene
This gene encodes subunit 3 of the splicing factor 3b protein complex. Splicing factor 3b, together with splicing factor 3a and a 12S RNA unit, forms the U2 small nuclear ribonucleoproteins complex (U2 snRNP). The splicing factor 3b/3a complex binds pre-mRNA upstream of the intron's branch site in a sequence independent manner and may anchor the U2 snRNP to the pre-mRNA. Splicing factor 3b is also a component of the minor U12-type spliceosome. Subunit 3 has also been identified as a component of the STAGA (SPT3-TAF(II)31-GCN5L acetylase) transcription coactivator-HAT (histone acetyltransferase) complex, and the TFTC (TATA-binding-protein-free TAF(II)-containing complex). These complexes may function in chromatin modification, transcription, splicing, and DNA repair. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1217 residues, UniProt reviewed canonical sequence.
>Q15393|SF3B3
1 MFLYNLTLQR ATGISFAIHG NFSGTKQQEI VVSRGKILEL LRPDPNTGKV HTLLTVEVFG
61 VIRSLMAFRL TGGTKDYIVV GSDSGRIVIL EYQPSKNMFE KIHQETFGKS GCRRIVPGQF
121 LAVDPKGRAV MISAIEKQKL VYILNRDAAA RLTISSPLEA HKANTLVYHV VGVDVGFENP
181 MFACLEMDYE EADNDPTGEA AANTQQTLTF YELDLGLNHV VRKYSEPLEE HGNFLITVPG
241 GSDGPSGVLI CSENYITYKN FGDQPDIRCP IPRRRNDLDD PERGMIFVCS ATHKTKSMFF
301 FLAQTEQGDI FKITLETDED MVTEIRLKYF DTVPVAAAMC VLKTGFLFVA SEFGNHYLYQ
361 IAHLGDDDEE PEFSSAMPLE EGDTFFFQPR PLKNLVLVDE LDSLSPILFC QIADLANEDT
421 PQLYVACGRG PRSSLRVLRH GLEVSEMAVS ELPGNPNAVW TVRRHIEDEF DAYIIVSFVN
481 ATLVLSIGET VEEVTDSGFL GTTPTLSCSL LGDDALVQVY PDGIRHIRAD KRVNEWKTPG
541 KKTIVKCAVN QRQVVIALTG GELVYFEMDP SGQLNEYTER KEMSADVVCM SLANVPPGEQ
601 RSRFLAVGLV DNTVRIISLD PSDCLQPLSM QALPAQPESL CIVEMGGTEK QDELGERGSI
661 GFLYLNIGLQ NGVLLRTVLD PVTGDLSDTR TRYLGSRPVK LFRVRMQGQE AVLAMSSRSW
721 LSYSYQSRFH LTPLSYETLE FASGFASEQC PEGIVAISTN TLRILALEKL GAVFNQVAFP
781 LQYTPRKFVI HPESNNLIII ETDHNAYTEA TKAQRKQQMA EEMVEAAGED ERELAAEMAA
841 AFLNENLPES IFGAPKAGNG QWASVIRVMN PIQGNTLDLV QLEQNEAAFS VAVCRFSNTG
901 EDWYVLVGVA KDLILNPRSV AGGFVYTYKL VNNGEKLEFL HKTPVEEVPA AIAPFQGRVL
961 IGVGKLLRVY DLGKKKLLRK CENKHIANYI SGIQTIGHRV IVSDVQESFI WVRYKRNENQ
1021 LIIFADDTYP RWVTTASLLD YDTVAGADKF GNICVVRLPP NTNDEVDEDP TGNKALWDRG
1081 LLNGASQKAE VIMNYHVGET VLSLQKTTLI PGGSESLVYT TLSGGIGILV PFTSHEDHDF
1141 FQHVEMHLRS EHPPLCGRDH LSFRSYYFPV KNVIDGDLCE QFNSMEPNKQ KNVSEELDRT
1201 PPEVSKKLED IRTRYAFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SF3B3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 25 nTPM
- lymph node: 23 nTPM
- skeletal muscle: 22 nTPM
- thymus: 22 nTPM
- bone marrow: 21 nTPM
- ovary: 20 nTPM
Single-cell type
- esophageal apical cells: 772 nCPM
- esophageal suprabasal cells: 147 nCPM
- erythrocyte progenitors: 132 nCPM
- megakaryocyte progenitors: 105 nCPM
- monocyte progenitors: 95 nCPM
- suprabasal keratinocytes: 79 nCPM
Immune cell
- T-reg: 40 nTPM
- MAIT T-cell: 39 nTPM
- naive CD4 T-cell: 39 nTPM
- total PBMC: 38 nTPM
- memory CD8 T-cell: 38 nTPM
- gdT-cell: 36 nTPM
Brain region
- cerebellum: 50 nTPM
- choroid plexus: 42 nTPM
- white matter: 41 nTPM
- hypothalamus: 38 nTPM
- cerebral cortex: 36 nTPM
- hippocampal formation: 35 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.18
- gnomAD pLI
- 1
- gnomAD missense Z
- 5.18
- DepMap mean gene effect
- -2.49
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- mRNA splicing, via spliceosome
- negative regulation of protein catabolic process
- positive regulation of DNA-templated transcription
- regulation of DNA repair
- regulation of RNA splicing
- RNA splicing
- RNA splicing, via transesterification reactions
- U2-type prespliceosome assembly
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RSE1/DDB1/CPSF1, C-terminal
- WD40/YVTN repeat-like-containing domain superfamily
- RSE1/DDB1/CPSF1, first beta-propeller
- WD40-repeat-containing domain superfamily
- RSE1/DDB1/CPSF1
- RSE1/DDB1/CPSF1, second beta-propeller
- CPSF A subunit region
- RSE1/DDB1/CPSF1 first beta-propeller
- RSE1/DDB1/CPSF1 second beta-propeller
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SF3B3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SF3B3 as an antibody target. Whether an autoantibody or antibody against SF3B3 could matter depends on whether native SF3B3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SF3B3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SF3B3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...